Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome.
Pulmonary embolism (PE) is a rare but life-threatening condition, which needs emergent treatment in children. Though anticoagulation is the standard treatment for PE, recent studies revealed intrapulmonary thrombolytic therapy may produce more rapid clot lysis and less systemic complications in adult patients. We reported a 10-year-old girl who had diffused multiple pulmonary emboli due to primary antiphospholipid syndrome. The thrombi persisted in spite of intravenous heparin infusion for 3 days, which resolved quickly after intrapulmonary streptokinase infusion for 12 hours.
Huang
Hsin-Ju
HJ
Department of Pediatrics, College of Medicine, National Cheng Kung University Hospital, 138, Sheng Li Road, Tainan, 70428, Taiwan.
Wang
Jieh-Neng
JN
Tsai
Yu-Chien
YC
Lin
Chia-Shiang
CS
Wu
Jing-Ming
JM
D000208:Acute Disease; D016736:Antiphospholipid Syndrome / Q000150:complications*; D002648:Child; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage*; D015912:Thrombolytic Therapy / Q000379:methods*
D006495:Heparin, Low-Molecular-Weight; D013300:Streptokinase